FDA inspection
Glaxo Smith Kline UK: FDA inspection ending Mar 29, 2000
FDA inspection 20678 · Voluntary Action Indicated (VAI) · Greenford
Key facts
| Inspection ID | 20678 |
|---|---|
| Firm | Glaxo Smith Kline UK |
| FEI number | 3000263379 |
| Address | 889 Greenford Road |
| City | Greenford |
| Fiscal year | 2000 |
| Inspection end date | Mar 29, 2000 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Post Mrkt Surv & Epid: Human Drugs |
| Product type | Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data